IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
24 Abril 2024 - 2:00AM
IMCD Spain expands its Pharmaceuticals presence with the
acquisition of Cobapharma
ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V.
(“IMCD” or “Company”), a leading distributor of speciality
chemicals and ingredients, today announces that IMCD Spain has
signed an agreement to acquire 100% of the shares in Cobapharma,
S.L.U, a European distributor in the pharmaceutical and
nutraceutical industry.
Established in 2011 and headquartered in Barcelona, Spain,
Cobapharma provides an extensive portfolio of Active Pharmaceutical
Ingredients (APIs) as well as nutraceutical ingredients. With 20
employees, Cobapharma represents leading suppliers and generated a
revenue of approximately EUR 19 million in the financial
year that ended December 31, 2023.
‘Cobapharma is a rapidly growing distributor in the
pharmaceutical and nutraceutical industry. Their esteemed
reputation for providing high-quality APIs and nutraceutical
ingredients perfectly complements our existing portfolio. The
alignment of our business models will enhance our ability to serve
our customers and partners’ comments John Robinson, Business Group
Director IMCD Pharmaceuticals.
‘We are excited to join IMCD. This acquisition opens new
opportunities for Cobapharma to expand its offerings and reach a
broader customer base. We look forward to leveraging IMCD's
expertise and network to accelerate our growth and value creation
to our customers’, says Gianluca Galimberti, General Manager
Cobapharma.
The closing of the transaction is subject to customary
(regulatory) closing conditions and is expected to take place in
the second quarter of 2024.
Attached, the press release in PDF format, the main visual and
photo caption.
- Photo caption_IMCD Spain expands its Pharmaceuticals presence
with the acquisition of Cobapharma
- Photo_IMCD Spain expands its Pharmaceuticals presence with the
acquisition of Cobapharma
- PR_IMCD Spain expands its Pharmaceuticals presence with the
acquisition of Cobapharma
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
